Abstract

IntroductionObservational studies suggest HIV and human papillomavirus (HPV) infections may have multiple interactions. We reviewed the strength of the evidence for the influence of HIV on HPV acquisition and clearance, and the influence of HPV on HIV acquisition.MethodsWe performed meta‐analytic systematic reviews of longitudinal studies of HPV incidence and clearance rate by HIV status (review 1) and of HIV incidence by HPV status (review 2). We pooled relative risk (RR) estimates across studies using random‐effect models. I 2 statistics and subgroup analyses were used to quantify heterogeneity across estimates and explore the influence of participant and study characteristics including study quality. Publication bias was examined quantitatively with funnel plots and subgroup analysis, as well as qualitatively.Results and DiscussionIn review 1, 37 publications (25 independent studies) were included in the meta‐analysis. HPV incidence (pooled RR = 1.55, 95% CI: 1.29 to 1.88; heterosexual males: pooled RR = 1.95, 95% CI: 1.62, 2.34; females: pooled RR = 1.63, 95% CI: 1.26 to 2.11; men who have sex with men: pooled RR = 1.36, 95% CI: 1.01 to 1.82) and high‐risk HPV incidence (pooled RR = 2.20, 95% CI: 1.90 to 2.54) was approximately doubled among people living with HIV (PLHIV) whereas HPV clearance rate (pooled RR = 0.53, 95% CI: 0.42 to 0.67) was approximately halved. In review 2, 14 publications (11 independent studies) were included in the meta‐analysis. HIV incidence was almost doubled (pooled RR = 1.91, 95% CI 1.38 to 2.65) in the presence of prevalent HPV infection. There was more evidence of publication bias in review 2, and somewhat greater risk of confounding in studies included in review 1. There was some evidence that adjustment for key confounders strengthened the associations for review 2. Misclassification bias by HIV/HPV exposure status could also have biased estimates toward the null.ConclusionsThese results provide evidence for synergistic HIV and HPV interactions of clinical and public health relevance. HPV vaccination may directly benefit PLHIV, and help control both HPV and HIV at the population level in high prevalence settings. Our estimates of association are useful for mathematical modelling. Although observational studies can never perfectly control for residual confounding, the evidence presented here lends further support for the presence of biological interactions between HIV and HPV that have a strong plausibility.

Highlights

  • Observational studies suggest HIV and human papillomavirus (HPV) infections may have multiple interactions

  • Publications were examined for eligibility to include prospective cohort studies, randomized controlled trials, and case– control studies nested within a cohort or trial, where the time sequence between HIV and HPV infections was determined, that were published in the English language, and that measured active genital HPV infection by detection of the virus in either cervical, penile or anal swabs or cervico-vaginal lavage fluid using a test based on HPV DNA identification

  • In review 1, of the effect of HIV status on subsequent HPV acquisition and clearance, we extracted data from a total of 41 publications reporting on 27 independent studies [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54]

Read more

Summary

Introduction

Observational studies suggest HIV and human papillomavirus (HPV) infections may have multiple interactions. Results and Discussion: In review 1, 37 publications (25 independent studies) were included in the meta-analysis. In review 2, 14 publications (11 independent studies) were included in the meta-analysis. There was more evidence of publication bias in review 2, and somewhat greater risk of confounding in studies included in review 1. Observational studies can never perfectly control for residual confounding, the evidence presented here lends further support for the presence of biological interactions between HIV and HPV that have a strong plausibility. Sub-Saharan Africa faces a dual disease burden as the region has some of the highest rates of cervical cancer incidence and deaths, [4] and it accounts for approximately 70% of people living with HIV (PLHIV) worldwide [5,6]. HIV is believed to exacerbate the burden of cervical cancer

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call